Does low vitamin D increase musculoskeletal pain by modulating inflammation?

Vitamin D plays a multifaceted role in skeletal health and immune regulation, with its status serving as a critical marker for chronic pain and inflammatory activity.

Clinical and observational evidence

Extensive observational research consistently demonstrates a significant inverse correlation between serum 25-hydroxyvitamin D [25(OH)D] levels and the prevalence or intensity of musculoskeletal pain. Individuals with deficiency (typically <20 ng/mL) exhibit markedly higher rates of chronic low back pain, non-specific musculoskeletal pain, and fibromyalgia symptoms compared to those with sufficient levels. Meta-analyses confirm that patients with chronic pain often have significantly lower mean 25(OH)D levels than healthy controls. While supplementation results are most robust in those with a baseline deficiency, large-scale trials in non-deficient populations—such as the D-Health trial—often show neutral results, suggesting that the clinical benefit is most pronounced when correcting an existing deficit.

Mechanistic explanations

The relationship between vitamin D and pain is supported by its role as a potent immunomodulator.

• VDR Activation: The active metabolite, 1,25-dihydroxyvitamin D3 (calcitriol), binds to Vitamin D Receptors (VDR) on immune cells, including macrophages and T cells.
• NF-κB Inhibition: This binding directly antagonizes the NF-κB pathway, a central mediator of inflammation, thereby suppressing the transcription of pro-inflammatory cytokines such as TNF-α, IL-1, and IL-6. These cytokines are known to sensitize nociceptors (pain receptors), contributing to musculoskeletal pain signaling.
• Immune Cell Polarization: Vitamin D shifts the T-helper cell balance toward a Th2-dominant environment and enhances the induction of regulatory T cells (Tregs). These Tregs secrete anti-inflammatory cytokines like IL-10 while simultaneously inhibiting the development of Th1 and Th17 cells, which are primary drivers of hyper-inflammatory states.

Clinical implications

In practical terms, vitamin D influences systemic inflammation by lowering pro-inflammatory markers such as IFN-γ and IL-6. Clinical data from various cohorts, including those with chronic kidney disease, demonstrates that maintaining adequate vitamin D levels can mitigate the "cytokine storms" or persistent low-grade inflammation that contribute to tissue-level symptoms and chronic pain.

Bottom line

Low vitamin D status is strongly associated with increased musculoskeletal pain, particularly in deficient populations. This link is driven by vitamin D’s ability to activate the VDR, inhibit NF-κB signaling, and shift the immune profile toward an anti-inflammatory state, effectively dampening the pro-inflammatory signaling that sensitizes pain pathways.